Loading...
TEVA PHARMACEUTICALS USA, INC. — Theophylline Import Profile: Suppliers, Formulations & Sources
Loading...
Pharmaceutical Importer · #8 buyer for Theophylline · $256.1K import value · 11 shipments · UNITED STATES · DGFT Verified
TEVA PHARMACEUTICALS USA, INC. is the #8 importer of Theophylline from India with $256.1K in import value and 11 verified shipments. TEVA PHARMACEUTICALS USA, INC. holds a 2.6% market share in Theophylline imports based in UNITED STATES. The company sources from 1 verified supplier across 4 formulations shipped to 1 country. Overall, TEVA PHARMACEUTICALS USA, INC. imports 3 pharmaceutical products worth $9.2M across 2 therapeutic categories.
Verified from 11 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| WATSON PHARMA PRIVATE LIMITED | $256.1K | 11 | 100.0% |
TEVA PHARMACEUTICALS USA, INC. sources Theophylline from 1 verified Indian supplier based on 11 customs records. The primary supplier is WATSON PHARMA PRIVATE LIMITED accounting for 100.0% of imports.
Buyers ranked immediately above and below #8 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 6 | INOVA PHARMA (THAILAND) CO LTD | THAILAND | $450.0K | 9 | $50.0K |
| 7 | GLENMARK PHARMACEUTICALS INC USA | UNITED STATES | $445.1K | 19 | $23.4K |
| 8 | TEVA PHARMACEUTICALS USA, INC. ★ | UNITED STATES | $409.8K | 11 | $37.3K |
| 9 | INOVA PHARMACEUTICALS SINGAPORE | SINGAPORE | $382.0K | 12 | $31.8K |
| 11 | R S SOLUTIONS | UNITED STATES | $317.2K | 8 | $39.7K |
TEVA PHARMACEUTICALS USA, INC. ranks #8 among 268 Theophylline importers from India. Average shipment value of $37.3K compared to the market average of $27.7K. The closest competitors by value are INOVA PHARMA (THAILAND) CO LTD and GLENMARK PHARMACEUTICALS INC USA.
Destination countries from 11 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $256.1K | 11 | 100.0% |
TEVA PHARMACEUTICALS USA, INC. imports Theophylline to 1 country. The primary destination is UNITED STATES receiving 100.0% of shipments worth $256.1K.
| Formulation | Value | Shipments |
|---|---|---|
| THEOPHYLLINE EXTENDED RELEASE TABLETS 30 | $182.0K | 6 |
| THEOPHYLLINE EXTENDED RELEASE TABLETS 45 | $31.2K | 3 |
| THEOPHYLLINE EXTENDED RELEASE TABLETS 450MG 100'S (Batch No 1125600030) ( Mfg Date 09.12.2024 Expiry Date 30.11.2026 (91 | $24.7K | 1 |
| THEOPHYLLINE EXTENDED RELEASE TABLETS 300MG 100'S (Batch No 1125600029) ( Mfg Date 09.12.2024 Expiry Date 30.11.2026 (13 | $18.2K | 1 |
TEVA PHARMACEUTICALS USA, INC. imports 4 distinct Theophylline formulations from India. The top formulation is THEOPHYLLINE EXTENDED RELEASE TABLETS 30 with 6 shipments worth $182.0K.
What TEVA PHARMACEUTICALS USA, INC. and other importers must comply with to import Theophylline from India
U.S. Food and Drug Administration (FDA)
Abbreviated New Drug Application (ANDA) for generic drugs, requiring bioequivalence studies and compliance with 21 CFR. Indian manufacturing sites must pass FDA pre-approval inspection.
Typical timeline: 10–18 months for ANDA approval
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA prior to approval
India exported $7.4M worth of Theophylline through 1,108 shipments from 114 suppliers to 67 countries, serving 268 buyers globally. TEVA PHARMACEUTICALS USA, INC. imports $256.1K of this total, accounting for 2.6% of India's Theophylline exports with 11 shipments from UNITED STATES. This is verified from 11 customs shipment records covering 4 distinct formulations.
TEVA PHARMACEUTICALS USA, INC.'s average Theophylline order value is $23.3K per consignment, based on 11 shipments totaling $256.1K. TEVA PHARMACEUTICALS USA, INC. is based in UNITED STATES and ranks #8 among all Theophylline importers from India by value. The company sources from 1 verified supplier in India.
TEVA PHARMACEUTICALS USA, INC. sources Theophylline from 1 verified Indian supplier: WATSON PHARMA PRIVATE LIMITED ($256.1K, 100.0%). This is based on 11 customs records.
TEVA PHARMACEUTICALS USA, INC. ranks #8 among 268 Theophylline importers from India with a 2.6% market share. The top 3 importers are SUNSHINE HEALTHCARE LANKA LIMITED ($2.1M), GLENMARK PHARMACEUTICALS INC., USA ($1.0M), INOVA PHARMACEUTICALS (SINGAPORE) ($757.9K). TEVA PHARMACEUTICALS USA, INC. processed 11 shipments from UNITED STATES.
TEVA PHARMACEUTICALS USA, INC. imports 3 products worth $9.2M. Beyond Theophylline, top products include Carvedilol, Diltiazem. View the complete TEVA PHARMACEUTICALS USA, INC. profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Theophylline — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify import regulations and drug registration requirements with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access order-level details, pricing data, supplier connections, and competitive analysis for TEVA PHARMACEUTICALS USA, INC.'s Theophylline imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
TEVA PHARMACEUTICALS USA, INC.
Full Company Profile →
3 products · $9.2M total trade · 2 categories
Drug Listing with FDA; Import Alert screening; Customs entry via FDA PREDICT system
US-specific labeling per 21 CFR 201 including NDC number, lot, expiry, dosage in English
Note: Subject to FDA Import Alerts and Automatic Detention if facility has open Form 483 observations.
Regulatory information is provided for general reference based on publicly available FDA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with FDA or qualified regulatory affairs professionals for case-specific guidance.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 67+ countries, 268+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Verified from customs records
Access shipment-level records, supplier contacts, and formulation details for TEVA PHARMACEUTICALS USA, INC..
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Theophylline. For current order-level data, contact TransData Nexus.